OCM
DCPH

Osterweis Capital Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Osterweis Capital Management’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-83,670
Closed -$4.78M – 144
2020
Q4 		$4.78M Buy
83,670
+27,465
+49% +$1.63M 0.28% 86
2020
Q3 		$2.88M Buy
+56,205
New +$2.75M 0.19% 88

Other funds holding DCPH

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Osterweis Capital Management's DCPH Position: Q1 2021 in Review

Osterweis Capital Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q1 2021, closing a stake of 83,670 shares — an estimated $4.78M sold.

Osterweis Capital Management first reported a position in DCPH in Q3 2020 and held it in 2 quarters. The position peaked at $4.78M in Q4 2020. 167 funds tracked by Wall St. Rank hold DCPH as of Q1 2021.

  • Osterweis Capital Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Osterweis Capital Management sold 83,670 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q1 2021, an estimated $4.78M.
  • Osterweis Capital Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 2 quarters.
  • Osterweis Capital Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $4.78M in Q4 2020.
  • 167 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2021.

Based on Osterweis Capital Management's 13F filing for Q1 2021, filed 14 May 2021.